Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
MabSpace Biosciences Merged with HJB to Form Transcenta Holding, a Fully Integrated Leading Global Biotherapeutics Company 2019-01-02 12:37
InventisBio and Betta Pharma to Co-Develop Novel Drug for Non-Small Cell Lung Cancer 2018-12-29 03:33
Bridge Biotherapeutics Announces a Successful Activation of U.S. Clinical Trial Sites for BBT-401 Phase 2 Study 2018-12-28 07:00
China's NMPA Approves Innovent's Anti-PD-1 Antibody Tyvyt® (Sintilimab injection) for Hodgkin's Lymphoma 2018-12-27 16:45
I-Mab Receives U.S. FDA IND Approval for Proprietary Anti-GM-CSF Monoclonal Antibody TJM2 2018-12-24 11:45
CStone Pharmaceuticals announces initiation of CS1001 Phase I Study in U.S., patient enrollment under way 2018-12-21 17:50
Bridge Biotherapeutics Signs US$40M License Agreement with Daewoong Pharmaceutical for Co-development of UC Drug Candidate 2018-12-19 08:00
NeuClone Announces its Sixth Biosimilar Candidate Perjeta(R) (Pertuzumab) for use in Combination Therapy with Herceptin(R) (Trastuzumab) 2018-12-17 21:30
I-Mab and CSPC Pharma Announce Strategic Partnership for Long-acting GLP-1 Fc Program 2018-12-17 19:10
China Biologic Announces Dismissal of Lawsuit Filed in Cayman Islands by Former Chairman 2018-12-14 21:00
Innovent Announces Two Clinical Studies with the Anti-VEGF Monoclonal Antibody IBI305, a Biosimilar Candidate to Avastin (Bevacizumab), Met Primary Endpoints 2018-12-13 08:00
Mayne Pharma receives FDA approval of Tolsura™ (SUBA®-itraconazole capsules) for the treatment of certain fungal infections 2018-12-12 07:05
Cerecin Sponsors and Presents at Alzheimer's Disease Therapeutics: Alternatives to Amyloid Symposium 2018-12-11 16:05
World-first Approval For Multiple Myeloma Drug APLIDIN(R) 2018-12-11 15:10
Oxford BioTherapeutics Expands Strategic Collaboration with WuXi Biologics and Licenses WuXiBody™ Platform for Five Bispecific Antibody Programs for up to $450 Million 2018-12-11 09:47
CStone Pharmaceuticals Appoints Former MSD Global Oncology Early Development Executive Director Archie Tse, M.D., Ph.D., as the newly established SVP, Chief Translation Medicine Officer 2018-12-10 15:38
WuXi Biologics Wins SCRIP Award for "Best Company in an Emerging Market" 2018-12-06 18:12
CARsgen Presents Preliminary Results of CAR-BCMA T Cell Therapy at ASH 2018 2018-12-04 20:00
TRACON Pharmaceuticals and I-Mab Biopharma Announce Strategic Partnerships for Multiple Immuno-Oncology Programs 2018-11-29 15:40
Spring Pharmaceutical Group Inc. Starts Harvesting Seed Pods from Its Acer Truncatum Bunge Planting Bases 2018-11-27 20:00
1 134 135 136 137 138 165